DocDollars

Ucb Biosciences Inc.

NC · United States · Reporting entity ID 100000010780

Total reported 2019–2025
$9.32M
#510 of 2,960 reporting companies — 0% of all reported industry payments
$1.12M in general payments across 714 records, plus $8.21M in research funding across 1,037 records.

How it breaks down

General payments $1,116,231
Research funding $8,207,086

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ucb Biosciences Inc. reported $9.32M to US doctors and teaching hospitals from 2019 to 2025, ranking #510 of 2,960 reporting companies. 88% of that was research funding and 12% general payments such as consulting, speaking, food and travel. 714 general payment records and 1,037 research records were filed.

Common questions about Ucb Biosciences Inc.

How much has Ucb Biosciences Inc. paid US doctors?

Ucb Biosciences Inc. reported $9,323,317 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,116,231 in general payments, $8,207,086 in research funding.

How does Ucb Biosciences Inc. rank among drug and device companies?

It ranks #510 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ucb Biosciences Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.